Futura Medical plc. (FUM) Earns “corporate” Rating from N+1 Singer
Futura Medical plc. (LON:FUM)‘s stock had its “corporate” rating restated by stock analysts at N+1 Singer in a research report issued to clients and investors on Friday.
Futura Medical plc. (LON FUM) traded up 0.000% on Friday, hitting GBX 26.625. 198,712 shares of the stock were exchanged. The stock’s market cap is GBX 31.99 million. Futura Medical plc. has a 1-year low of GBX 28.00 and a 1-year high of GBX 74.80. The company’s 50 day moving average is GBX 40.30 and its 200 day moving average is GBX 50.29.
TRADEMARK VIOLATION WARNING: “Futura Medical plc. (FUM) Earns “corporate” Rating from N+1 Singer” was originally posted by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/09/22/futura-medical-plc-fum-given-corporate-rating-at-n1-singer.html.
Futura Medical plc. Company Profile
Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin.
Receive News & Ratings for Futura Medical plc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical plc. and related companies with MarketBeat.com's FREE daily email newsletter.